Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Pharmacogenetic determinants of imatinib, dasatinib and nilotinib pharmacokinetics in chronic myeloid leukaemia patients
- F. De, A. Alessandra, +6 authors Carlo Francesco Di
- Medicine
- 2012
Imatinib is the gold standard for the treatment of chronic myeloid leukaemia (CML) [1]. Several studies revealed correlation between imatinib trough plasma levels and clinical response, suggesting… Expand
Determinanti farmacogenetici della farmacocinetica del mitotane: studio condotto su pazienti affetti da carcinoma corticosurrenalico
- Francia Silvia De, Martino Francesca De, +6 authors Carlo Francesco Di
- Medicine
- 2011
New hplc-mass spectrometry method for the simultaneous quantification in human plasma of the antileukemia drugs imatinib, dasatinib, and nilotinib
- Francia Silvia De, D’Avolio Antonio, +4 authors Carlo Francesco Di
- Medicine
- 2010
Clinical and biochemical effects of adjuvant mitotane treatment in patients with adrenocortical cancer (ACC)
- F. Daffara, F. De, +6 authors M. Terzolo
- Medicine
- 28 April 2007